Phase-III Clinical and Bioequivalence Study to Evaluate Efficacy and safety of Antihyperparathyroidism and Antianginal D
Wedi'i Gadw mewn:
Prif Awdur: | Choulwar Amol K. |
---|---|
Fformat: | Llyfr |
Iaith: | Saesneg |
Cyhoeddwyd: |
Mumbai
NMIMS-SPPSPTM
2013
|
Pynciau: | |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
BY USING DIFFERENT ANALYTICAL TECHNIQUES, ANALYSING THE DESIGNED DRUG RANOLAZINE -AN ANTIANGINAL DRUG
gan: PRUTHA PATEL
Cyhoeddwyd: (2019) -
Advanced accounts volume 2
gan: Shukla, M.
Cyhoeddwyd: (1997) -
Bioequivalence Studies to Evaluate Efficacy and Safty of Antiretroval and Antituberculosis Drug
gan: Halde Supriya
Cyhoeddwyd: (2012) -
ISDN : D CHANNEL IN DIALOGUE
gan: GOLLER, J
Cyhoeddwyd: (2000) -
Conductionof Clilical Phase in Bioavailability and Bioequivalence Study
gan: Singh Abhishek Bijoy